Wells Fargo
SRTA

Wells Fargo’s Strata Critical Medical Inc SRTA Stock Holding History

Wells Fargo’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Sell
26,685
-51,139
-66% -$246K ﹤0.01% 5051
2025
Q4 		$374K Buy
77,824
+26,654
+52% +$129K ﹤0.01% 4686
2025
Q3 		$259K Sell
51,170
-13,630
-21% -$60.2K ﹤0.01% 4780
2025
Q2 		$261K Buy
64,800
+29,538
+84% +$96.1K ﹤0.01% 4609
2025
Q1 		$96.3K Buy
35,262
+1,204
+4% +$4.32K ﹤0.01% 5114
2024
Q4 		$145K Buy
34,058
+7,418
+28% +$28.2K ﹤0.01% 4982
2024
Q3 		$78.3K Sell
26,640
-7,480
-22% -$23.8K ﹤0.01% 5154
2024
Q2 		$119K Buy
34,120
+10,945
+47% +$36.5K ﹤0.01% 4832
2024
Q1 		$66K Buy
23,175
+2,676
+13% +$8.26K ﹤0.01% 5142
2023
Q4 		$72.4K Buy
20,499
+3,697
+22% +$10.6K ﹤0.01% 5101
2023
Q3 		$43.5K Sell
16,802
-11,779
-41% -$41.4K ﹤0.01% 5249
2023
Q2 		$113K Buy
28,581
+13,733
+92% +$43.6K ﹤0.01% 4964
2023
Q1 		$50.2K Buy
14,848
+9,195
+163% +$37.5K ﹤0.01% 5157
2022
Q4 		$20.2K Sell
5,653
-1,833
-24% -$7.83K ﹤0.01% 5254
2022
Q3 		$30K Sell
7,486
-20,379
-73% -$105K ﹤0.01% 5185
2022
Q2 		$125K Buy
27,865
+19,575
+236% +$141K ﹤0.01% 4518
2022
Q1 		$70K Sell
8,290
-8,899
-52% -$62.5K ﹤0.01% 5492
2021
Q4 		$151K Buy
17,189
+5,332
+45% +$50.7K ﹤0.01% 5422
2021
Q3 		$123K Sell
11,857
-76,278
-87% -$666K ﹤0.01% 5298
2021
Q2 		$925K Sell
88,135
-55,833
-39% -$551K ﹤0.01% 4260
2021
Q1 		$1.48M Buy
143,968
+137,828
+2,245% +$1.92M ﹤0.01% 3959
2020
Q4 		$68K Buy
+6,140
New +$62.6K ﹤0.01% 5488

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's SRTA Position: Q1 2026 in Review

Wells Fargo reduced its Strata Critical Medical Inc (SRTA) stake by 66% in Q1 2026, selling an estimated $246K and leaving 26,685 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #5051.

Wells Fargo first reported a position in SRTA in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.48M in Q1 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Wells Fargo held 26,685 shares of Strata Critical Medical Inc worth $112K as of Q1 2026.
  • Wells Fargo sold 51,139 Strata Critical Medical Inc shares in Q1 2026, an estimated $246K.
  • Strata Critical Medical Inc made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5051 holding.
  • Wells Fargo first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 22 quarters since.
  • Wells Fargo's Strata Critical Medical Inc position peaked at $1.48M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.